Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab [Corrigendum]

Nudleman E, Wolfe JD, Woodward MA, Yonekawa Y, Williams GA, Hassan TS. Clinical Ophthalmology. 2016;10: 1053–1057.A units error was published on page 1055, column 2, as “3.1%”; the correct units are “μm” (3.1 μm).Read the original artic...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nudleman E, Wolfe JD, Woodward MA, Yonekawa Y, Williams GA, Hassan TS
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/b04edf6e052e42608bde9d4d6babb983
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b04edf6e052e42608bde9d4d6babb983
record_format dspace
spelling oai:doaj.org-article:b04edf6e052e42608bde9d4d6babb9832021-12-02T05:13:45ZWorsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab [Corrigendum]1177-5483https://doaj.org/article/b04edf6e052e42608bde9d4d6babb9832017-02-01T00:00:00Zhttps://www.dovepress.com/corrigendum-worsening-anatomic-outcomes-following-aflibercept-for-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Nudleman E, Wolfe JD, Woodward MA, Yonekawa Y, Williams GA, Hassan TS. Clinical Ophthalmology. 2016;10: 1053–1057.A units error was published on page 1055, column 2, as “3.1%”; the correct units are “μm” (3.1 μm).Read the original article.Nudleman EWolfe JDWoodward MAYonekawa YWilliams GAHassan TSDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 11, Pp 355-356 (2017)
institution DOAJ
collection DOAJ
language EN
topic Ophthalmology
RE1-994
spellingShingle Ophthalmology
RE1-994
Nudleman E
Wolfe JD
Woodward MA
Yonekawa Y
Williams GA
Hassan TS
Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab [Corrigendum]
description Nudleman E, Wolfe JD, Woodward MA, Yonekawa Y, Williams GA, Hassan TS. Clinical Ophthalmology. 2016;10: 1053–1057.A units error was published on page 1055, column 2, as “3.1%”; the correct units are “μm” (3.1 μm).Read the original article.
format article
author Nudleman E
Wolfe JD
Woodward MA
Yonekawa Y
Williams GA
Hassan TS
author_facet Nudleman E
Wolfe JD
Woodward MA
Yonekawa Y
Williams GA
Hassan TS
author_sort Nudleman E
title Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab [Corrigendum]
title_short Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab [Corrigendum]
title_full Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab [Corrigendum]
title_fullStr Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab [Corrigendum]
title_full_unstemmed Worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab [Corrigendum]
title_sort worsening anatomic outcomes following aflibercept for neovascular age-related macular degeneration in eyes previously well controlled with ranibizumab [corrigendum]
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/b04edf6e052e42608bde9d4d6babb983
work_keys_str_mv AT nudlemane worseninganatomicoutcomesfollowingafliberceptforneovascularagerelatedmaculardegenerationineyespreviouslywellcontrolledwithranibizumabcorrigendum
AT wolfejd worseninganatomicoutcomesfollowingafliberceptforneovascularagerelatedmaculardegenerationineyespreviouslywellcontrolledwithranibizumabcorrigendum
AT woodwardma worseninganatomicoutcomesfollowingafliberceptforneovascularagerelatedmaculardegenerationineyespreviouslywellcontrolledwithranibizumabcorrigendum
AT yonekaway worseninganatomicoutcomesfollowingafliberceptforneovascularagerelatedmaculardegenerationineyespreviouslywellcontrolledwithranibizumabcorrigendum
AT williamsga worseninganatomicoutcomesfollowingafliberceptforneovascularagerelatedmaculardegenerationineyespreviouslywellcontrolledwithranibizumabcorrigendum
AT hassants worseninganatomicoutcomesfollowingafliberceptforneovascularagerelatedmaculardegenerationineyespreviouslywellcontrolledwithranibizumabcorrigendum
_version_ 1718400493398523904